Cardinal Health (CAH) Gets a Hold Rating from RBC Capital


RBC Capital analyst George Hill reiterated a Hold rating on Cardinal Health (NYSE: CAH) yesterday and set a price target of $56. The company’s shares closed yesterday at $50.05, close to its 52-week low of $48.14.

According to TipRanks.com, Hill is a 1-star analyst with an average return of 0.0% and a 45.4% success rate. Hill covers the Services sector, focusing on stocks such as Walgreens Boots Alliance, Charles River Labs, and IQVIA Holdings Inc.

The word on The Street in general, suggests a Hold analyst consensus rating for Cardinal Health with a $58.75 average price target, implying a 17.4% upside from current levels. In a report issued on July 23, Cowen & Co. also reiterated a Hold rating on the stock with a $54 price target.

.

See today’s analyst top recommended stocks >>

The company has a one-year high of $75.75 and a one-year low of $48.14. Currently, Cardinal Health has an average volume of 3.45M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cardinal Health, Inc. is a healthcare services company providing pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts